Skip to main content

Urcuyo Delgado, Gabriela

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Urcuyo Delgado, Gabriela

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Related news

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Over the course of two days, experts presented the latest advances in vectors, different gene modification techniques and their transfer to clinical practice.

Related professionals

Pilar Lusilla Palacios

Pilar Lusilla Palacios

Psychiatry, Mental Health and Addictions
Read more
Nieves Martínez Luna

Nieves Martínez Luna

Predoctoral researcher
Psychiatry, Mental Health and Addictions
Read more
Fiorella Dellepiane Clarke

Fiorella Dellepiane Clarke

Postdoctoral researcher
Molecular Imaging and Therapy
Read more
Jenson Gerardo Maldonado Chávez

Jenson Gerardo Maldonado Chávez

Research technician
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.